Evidence map›Paper›PMID 26606984›Full record

ArticleItalian journal of pediatrics2015

A disorder of surfactant metabolism without identified genetic mutations.

Silvia Montella, Timothy J Vece, Claire Langston, Paola Carrera, Lawrence M Nogee, Aaron Hamvas, Angelo Manna, Mariarosaria Cervasio, Mara Cervasio, Francesca Santamaria

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Italian journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Silvia MontellaDepartment of Translational Medical Sciences, Federico II University, Via Sergio Pansini, 5 - 80131, Naples, Italy. amina2004@virgilio.it.
Timothy J VeceDepartment of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. tjvece@texaschildrens.org.
Claire LangstonDepartment of Pathology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. cxlangst@texaschildrens.org.
Paola CarreraDivision of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milano, Italy. carrerapaola9@gmail.com.
Lawrence M NogeeDepartment of Pediatrics, Division of Neonatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lnogee@jhmi.edu.
Aaron HamvasEdward Mallinckrodt Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, MO, USA. ahamvas@luriechildrens.org.
Angelo MannaDepartment of Translational Medical Sciences, Federico II University, Via Sergio Pansini, 5 - 80131, Naples, Italy. manna.ange@gmail.com.
Mariarosaria Cervasio
Mara CervasioDepartment of Advanced Biomedical Sciences, Anatomo-Pathology Unit, Federico II University, Naples, Italy. mara.cervasio@tin.it.
Francesca SantamariaDepartment of Translational Medical Sciences, Federico II University, Via Sergio Pansini, 5 - 80131, Naples, Italy. santamar@unina.it.
Federico II University Hospital · ITTexas Children's Hospital · USIRCCS Ospedale San Raffaele · ITJohns Hopkins University · USMallinckrodt (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurfactant metabolism disorders may result in diffuse lung disease in children. CASE PRESENTATION: We report a 3-years-old boy with dry cough, progressive hypoxemia, dyspnea and bilateral ground glass opacities at chest high-resolution computed tomography (HRCT) who had no variants in genes encoding surfactant proteins or transcription factors. Lung histology strongly suggested an abnormality of surfactant protein. A 7-month course of pulse intravenous high-dose methylprednisolone plus oral hydroxychloroquine and azithromycin led to gradual weaning from oxygen and oral steroids, and to improvement of cough and dyspnea. Over the follow-up period, hydroxychloroquine and azithromycin were not withdrawn as cough and dyspnea re-appeared at each attempt and disappeared at re-start. At 6 years of age chest HRCT still appeared unchanged, but clinical symptoms or signs were absent.

conclusionsIn children suspected of inborn errors of pulmonary surfactant metabolism who do not have a recognized genetic mutation, lung biopsy with consistent histology may help physicians to address the definitive diagnosis.

Indexed as

MutationBiopsyChild, PreschoolDNADNA Mutational AnalysisHumansLung Diseases, InterstitialMalePulmonary Surfactant-Associated Protein CTomography, X-Ray ComputedDNAPulmonary Surfactant-Associated Protein C

Identifiers

PMID26606984
PMCPMC4658764
OpenAlexW2177396688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.